Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Hoffmann

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2009
Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South AfricaChristopher J Hoffmann, Salome Charalambous, John Sim, et al.
Current HIV/AIDS Reports|August 7, 2025
Social and Structural Interventions to Reduce Strikingly High Post-Hospital Mortality for People Living with HIV in Sub-Saharan AfricaCassidy W Claassen, Tonderai Mabuto, Kate Shearer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2008
Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART programChristopher J Hoffmann, Salome Charalambous, Desmond J Martin, et al.
AIDS (London, England)|June 5, 2007
Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis BChristopher J Hoffmann, Salome Charalambous, Chloe L Thio, et al.
Plos One|July 30, 2021
HIV-related stigma and uptake of antiretroviral treatment among incarcerated individuals living with HIV/AIDS in South African correctional settings: A mixed methods analysisLucy Chimoyi, Christopher J Hoffmann, Harry Hausler, et al.
AIDS (London, England)|December 20, 2007
Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical eventsChristopher J Hoffmann, Katherine L Fielding, Salome Charalambous, et al.
The American Journal of Tropical Medicine and Hygiene|October 18, 2021
Causes and Outcomes of Admission and Investigation of Tuberculosis in Adults with Advanced HIV in South African Hospitals: Data from the TB Fast Track TrialPeter G Beckwith, Mpho Tlali, Salome Charalambous, et al.
The Lancet. HIV|November 16, 2019
Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trialAlison D Grant, Salome Charalambous, Mpho Tlali, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 4, 2015
Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South AfricaChristopher J Hoffmann, Silvia Cohn, Fildah Mashabela, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2012
Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studiesGilles Wandeler, Olivia Keiser, Lloyd Mulenga, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2009
Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South AfricaChristopher J Hoffmann, Salome Charalambous, John Sim, et al.
Current HIV/AIDS Reports|August 7, 2025
Social and Structural Interventions to Reduce Strikingly High Post-Hospital Mortality for People Living with HIV in Sub-Saharan AfricaCassidy W Claassen, Tonderai Mabuto, Kate Shearer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2008
Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART programChristopher J Hoffmann, Salome Charalambous, Desmond J Martin, et al.
AIDS (London, England)|June 5, 2007
Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis BChristopher J Hoffmann, Salome Charalambous, Chloe L Thio, et al.
Plos One|July 30, 2021
HIV-related stigma and uptake of antiretroviral treatment among incarcerated individuals living with HIV/AIDS in South African correctional settings: A mixed methods analysisLucy Chimoyi, Christopher J Hoffmann, Harry Hausler, et al.
AIDS (London, England)|December 20, 2007
Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical eventsChristopher J Hoffmann, Katherine L Fielding, Salome Charalambous, et al.
The American Journal of Tropical Medicine and Hygiene|October 18, 2021
Causes and Outcomes of Admission and Investigation of Tuberculosis in Adults with Advanced HIV in South African Hospitals: Data from the TB Fast Track TrialPeter G Beckwith, Mpho Tlali, Salome Charalambous, et al.
The Lancet. HIV|November 16, 2019
Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trialAlison D Grant, Salome Charalambous, Mpho Tlali, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 4, 2015
Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South AfricaChristopher J Hoffmann, Silvia Cohn, Fildah Mashabela, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2012
Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studiesGilles Wandeler, Olivia Keiser, Lloyd Mulenga, et al.
Pageof 14